HomeAcumen’s Alzheimer’s drug passes initial safety testA scientist looks at hypometabolic and hypoperfusion patterns at the

A scientist looks at hypometabolic and hypoperfusion patterns at the

A scientist looks at hypometabolic and hypoperfusion patterns at the single-subject level from a patient suffering from Alzheimer's disease at the Memory Centre at the Department of Readaptation and Geriatrics of the University Hospital (HUG), in Geneva, Switzerland, June 6, 2023. REUTERS/Denis Balibouse/File Photo